Sexual Dysfunction, Disability and Quality of Life in Patients With Multiple Sclerosis (MS)
Observational Study to Determine the Relationship Between the Degree of Disability and the Presence of Sexual Dysfunction and Between Sexual Dysfunction and the Quality of Life in Patients With Multiple Sclerosis (RRMS)
Sponsor: Merck KGaA, Darmstadt, Germany
Listed as NCT01080053, this observational or N/A phase trial focuses on Multiple Sclerosis, Relapsing Remitting and remains completed. Sponsored by Merck KGaA, Darmstadt, Germany, it has been updated 7 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jan 2019 — Jan 2021 [monthly]
Completed
-
Jun 2018 — Jan 2019 [monthly]
Completed
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Nov 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Merck KGaA, Darmstadt, Germany
- Merck Quimica Argentina S.A.I.C
For direct contact, visit the study record on ClinicalTrials.gov .